HIV-1 p66 pol

HIV-1 p66 pol Recombinant
Shipped with Ice Packs
In Stock

Description

Polyprotein Context and Domain Architecture

HIV-1 p66 Pol is initially embedded within the Gag-Pol polyprotein. Cryo-EM studies reveal that in this precursor state, the RT p66/p51-like subunits adopt distinct conformations compared to mature RT heterodimers . Key structural elements include:

  • Polymerase domain: Composed of fingers, palm, thumb, and connection subdomains.

  • RNase H domain: Located at the C-terminus, critical for RNA degradation during reverse transcription.

The mature RT heterodimer (p66/p51) forms when HIV-1 protease cleaves the RNase H domain from one p66 subunit, yielding a catalytically active p66 and a structural p51 subunit .

Enzymatic Activities

  • DNA Polymerase: Catalyzes RNA- and DNA-dependent DNA synthesis .

  • RNase H: Degrades RNA in RNA-DNA hybrids, enabling primer removal and strand transfer .

In the p66/p66 homodimer precursor, only one RNase H domain is solvent-accessible, enabling selective cleavage by HIV-1 protease to form the mature p66/p51 heterodimer . This asymmetry ensures strict 1:1 stoichiometry in virions .

Maturation and Dimerization

  • PR Activation: The flexible linkers between protease (PR) and RT in the polyprotein facilitate PR dimerization, which is essential for autocatalytic processing .

  • Conformational Dynamics: DEER EPR spectroscopy shows the p66 homodimer adopts an asymmetric conformation resembling the mature heterodimer, with one RNase H domain transiently exposed for cleavage .

Cryo-EM Insights into Polyprotein Structure

  • The RT region in HIV-1 Pol exhibits displaced p66/p51-like subunits, which sequester the F440/Y441 cleavage site, delaying maturation until dimerization stabilizes RT .

  • PR remains loosely associated with RT via flexible linkers, enabling spatial mobility required for activation .

Inhibitor Binding and Conformational Effects

  • Non-nucleoside RT inhibitors (NNRTIs) bind similarly to both p66/p66 homodimers and p66/p51 heterodimers, stabilizing dimer interfaces .

  • NMR studies show that NNRTI binding induces conformational changes in the p66/p66 homodimer, mirroring the heterodimer’s active site architecture .

Evolutionary Constraints

HIV-1 Pol exhibits high amino acid conservation across subtypes (e.g., subtype B, C, CRFs), underscoring its critical role in viral fitness . Notable conserved regions include:

  • Polymerase active site: Residues critical for dNTP binding and catalysis.

  • RNase H domain: Structural motifs essential for substrate recognition .

Table 2: Variant-Specific Polymorphisms in Pol Proteins5

RegionSubtypePolymorphismFrequencyImpact on ARVs
PR FlapsGroup OL10I15%Minimal
RT ThumbCRF01_AEV179E22%Unknown
IN CCDSubtype CT124A18%None

Subtype-Differentiating Residues

  • RT Connection Domain: M357 distinguishes subtypes A, B, and C .

  • RNase H Domain: Q480, Y483, and L491 vary across subtypes, potentially influencing RNase H activity .

Drug Target Considerations

  • NNRTI Resistance: Mutations like K103N and Y181C alter the NNRTI-binding pocket in p66, reducing inhibitor efficacy .

  • RNase H Inhibitors: High conservation of RNase H active site residues (e.g., D443, E478) makes this domain a promising target .

Product Specs

Introduction
The human immunodeficiency virus, or HIV, is a type of virus known as a retrovirus. It weakens the body's defense system, the immune system, making individuals susceptible to infections and illnesses that wouldn't typically affect healthy people. HIV specifically targets crucial immune cells, primarily a type of white blood cell called the CD4+ T cell, which plays a central role in coordinating the immune response. Other immune cells like macrophages and dendritic cells are also affected. The virus leads to a decline in CD4+ T cells through a few mechanisms. First, it directly destroys the infected cells. Second, it increases the rate at which these cells self-destruct (a process called apoptosis). Lastly, it makes the infected CD4+ T cells targets for other immune cells, called CD8 cytotoxic lymphocytes, which eliminate them. When the number of CD4+ T cells drops significantly, the body's ability to fight off infections is severely compromised. HIV is classified under the Lentivirus genus, part of the Retroviridae family. These viruses share common characteristics in their structure and behavior. Lentiviruses are known to cause long-term diseases with a delay between infection and the appearance of symptoms. They spread as single-stranded, positive-sense, enveloped RNA viruses. Upon entering a host cell, they use their own enzyme, reverse transcriptase, to convert their RNA into DNA. This viral DNA is then incorporated into the host cell's DNA using another viral enzyme called integrase, allowing the virus to use the cell's machinery for replication. Once inside, the virus can either remain inactive (latent) within the cell or become active, multiplying and releasing new virus particles to infect other cells.
Description
HIV-1 p66 Recombinant is a protein with a molecular weight of 71kDa, derived from the pol gene of HIV-1. It undergoes glycosylation, a process of adding sugar molecules, and is produced using a baculovirus-insect cell expression system.
Physical Appearance
A clear, colorless solution that has been sterilized by filtration.
Formulation
This protein solution is prepared in a buffer containing 30mM Tris pH-7, 0.15M NaCl, and 0.2mM EDTA.
Purity
The purity of this product is greater than 90.0% as determined by High-Performance Liquid Chromatography (HPLC) analysis and SDS-PAGE.
Stability
For short-term storage (up to 3 weeks), HIV-1 p66 Recombinant can be stored at 4°C. For long-term storage, it is recommended to store it below -18°C. The addition of a carrier protein (0.1% HSA or BSA) is advised for long-term storage. Repeated freezing and thawing should be avoided.
Applications
The HIV-1 p66 pol antigen is suitable for use in various laboratory techniques, including ELISA (Enzyme-Linked Immunosorbent Assay) and Western blots. It serves as an excellent antigen for the early identification of individuals who have recently become infected with HIV (seroconverters) with minimal issues related to specificity.
Source
Baculovirus Insect Cells.

Q&A

What is HIV-1 p66 Pol and how is it processed during viral maturation?

HIV-1 Pol is initially expressed as a single polypeptide chain within the Gag-Pol polyprotein. Following excision by HIV-1 protease, it forms a 66 kDa chain (p66) homodimer precursor. This precursor consists of two identical p66 subunits that then undergo further processing. HIV-1 protease selectively cleaves the ribonuclease H (RNase H) domain from only one of the subunits to yield the mature p66/p51 heterodimer that functions as the reverse transcriptase enzyme . This selective processing is critical for viral replication as it creates the functionally asymmetric mature enzyme where the p66 subunit contains both polymerase and RNase H activities, while the p51 subunit provides structural support .

How are the domains organized in HIV-1 reverse transcriptase?

The mature HIV-1 reverse transcriptase consists of a p66/p51 heterodimer with distinct domain organization:

SubunitSizeDomainsSubdomainsFunction
p66560 amino acidsPolymerase and RNase HFingers, palm, thumb, connectionContains active sites for polymerase and RNase H activities
p51440 amino acidsPolymerase onlyFingers, palm, thumb, connectionStructural scaffold

The polymerase domain has been compared to a human right hand and is composed of the fingers, palm, thumb, and connection subdomains . While p51 contains the same subdomains as the polymerase portion of p66, the relative arrangement of these subdomains differs significantly between the two subunits, with only p66 adopting a configuration capable of enzymatic activity .

Why does HIV-1 protease cleave only one RNase H domain in the p66 homodimer?

The selective cleavage of only one RNase H domain in the p66 homodimer occurs because of the inherent structural asymmetry of the homodimer. Despite being identical in amino acid sequence, the two p66 subunits adopt different conformations. Research using EPR spectroscopy demonstrates that this structural asymmetry exposes the linker between the RNase H and connection domains in only one of the subunits (designated p66′) .

The data suggest that the flexible, exposed linker in the open state of the p66′ subunit binds to the active site of HIV-1 protease in a configuration similar to extended peptide substrates . In contrast, the RNase H domain in the other subunit (designated p66) is sequestered when the RNase H domain folds, making the F440/Y441 cleavage site inaccessible to the protease . This selective accessibility ensures that only one RNase H domain is removed during maturation, preserving the essential enzymatic functions in the mature heterodimer.

What techniques are most effective for studying the spatial domain organization of HIV-1 p66 homodimer?

Pulsed Q-band double electron-electron resonance (DEER) EPR spectroscopy has proven highly effective for studying the spatial domain organization within the HIV-1 p66 homodimer. This technique allows researchers to measure intra- and intersubunit distances between spin labels attached to surface-engineered cysteines . The methodology involves:

  • Engineering surface-exposed cysteine residues at specific locations in the p66 protein

  • Attaching nitroxide spin labels to these cysteines

  • Performing DEER measurements to determine distances between labels

  • Using the collected distance data to develop structural models of the homodimer

This approach has successfully demonstrated that the structural subunit asymmetry found in the mature p66/p51 heterodimer is preserved in the p66 homodimer precursor . DEER EPR spectroscopy is particularly valuable for studying conformational changes, such as those induced by non-nucleoside inhibitors or binding of HIV-1 protease .

How can researchers express and purify stable HIV-1 Pol polyprotein for structural studies?

Expressing and purifying stable HIV-1 Pol polyprotein for structural studies requires several strategic modifications to prevent autocatalytic cleavage and improve stability. Based on recent research, the following approach has proven effective :

  • Start with an HIV-1 Pol construct from a well-characterized strain (e.g., BH10)

  • Incorporate an inactivating D25A mutation in the PR domain to prevent autocatalytic cleavage

  • Mutate amino acids at the RT/IN cleavage junction (RT L560 and IN F1) to D/D to reduce proteolytic degradation and improve solubility

  • Add an Sso7d tag and an HRV14 3C PR cleavage site at the N-terminus of the p6* region

For purification, a multi-step process is recommended:

  • Nickel affinity chromatography

  • HiTrap heparin chromatography

  • Gel filtration using a Superose 6 Increase 10/300 GL column

This optimized bacterial expression and purification procedure yields suitable amounts (>3 mg/liter) of pure protein for structural and biochemical studies . Quality control can be performed using SDS-PAGE and dynamic light scattering to confirm sample homogeneity and proper size distribution.

How can Shannon entropy analysis be applied to HIV-1 polymerase gene sequences?

Shannon entropy analysis of HIV-1 polymerase gene sequences provides a quantitative measure of sequence diversity that can be used to distinguish between recent and chronic HIV-1 infections. The methodology involves :

  • Amplifying the HIV-1 pol gene from patient samples

  • Performing Sanger sequencing of the amplified products

  • Analyzing sequence diversity using Shannon entropy calculations:

    • Calculating entropy scores for the complete pol gene

    • Creating sliding windows across the sequence to identify regions with differential diversity

    • Comparing entropy scores between recent and chronic infection samples

Research has shown significant differences in entropy scores between recent and chronic infections, with chronic infections typically showing higher sequence diversity. Statistical analysis of entropy data can be performed using unpaired t-tests, with a p-value ≤0.05 considered significant . This approach offers potential for developing molecular assays to determine HIV-1 infection recency, which is important for epidemiological studies and public health interventions.

What conformational changes occur in the p66 homodimer upon binding of non-nucleoside inhibitors?

The p66 homodimer undergoes significant conformational changes involving multiple domains upon binding of non-nucleoside inhibitors. DEER EPR spectroscopy studies have revealed that the addition of a non-nucleoside inhibitor induces a transition from a closed to a partially open state in one of the subunits (corresponding to the p66 subunit in the mature heterodimer) .

This conformational change specifically involves the thumb, palm, and finger domains in only one of the subunits, highlighting the inherent asymmetry in the homodimer's response to inhibitor binding. The selective conformational change in only one subunit further reinforces the structural asymmetry of the p66 homodimer that predisposes it to selective RNase H domain cleavage during maturation . Understanding these conformational dynamics is crucial for developing more effective non-nucleoside reverse transcriptase inhibitors and provides insights into the functional asymmetry of the enzyme.

What is the architecture of RT in the Pol polyprotein and how does it differ from mature RT?

The cryo-EM structure of HIV-1 Pol polyprotein reveals that RT adopts a heterodimer-like configuration within the polyprotein that differs significantly from mature RT. Key architectural features include :

  • The RT in Pol forms a structure with "RT p66-like" (RTp66L) and "RT p51-like" (RTp51L) subunits

  • The N-terminal regions of both RTp66L and RTp51L are displaced from their usual positions observed in crystal structures of mature RT

  • These displacements are attributed to the presence of PR upstream of the N-termini of RT subunits

  • The C-terminal portion of the RTp51L subunit shows high conformational flexibility, with ordered density ending after residue 428 of the connection subdomain

This heterodimeric arrangement of RT within the Pol polyprotein suggests that dimerization occurs early in maturation, which stabilizes the structure of the RNase H domain in RTp66L. This stabilization sequesters the F440/Y441 cleavage site in the folded polyprotein, making it inaccessible for cleavage, while the corresponding site in RTp51L remains accessible . These structural insights provide a mechanistic explanation for the selective processing of only one RNase H domain during maturation.

How do the enzymatic activities of RT in Pol compare to mature RT?

The RT embedded within the Pol polyprotein retains both reverse transcription and RNase H activities, but with notable differences compared to mature RT :

ActivityRT in PolMature RT (p66/p51)Significance
DNA polymeraseActive but different pause patternsReference activitySuggests different substrate engagement
RNase HActive, no off-target cleavages despite two RNase H domainsReference activityIndicates selective activation of only one RNase H domain

When a DNA aptamer was used as a polymerase substrate, the pause patterns during DNA synthesis differed between mature HIV-1 RT p66/p51 and the RT embedded in Pol, suggesting differences in substrate engagement . Importantly, despite the presence of two RNase H domains in Pol, no off-target cleavages were observed in RNase H assays, indicating that only one RNase H domain is catalytically active even in the precursor form .

These findings align with previous studies showing that HIV-1 virions containing a PR-RT fusion retain both PR and RT activities and can produce mature infectious virions that are morphologically indistinguishable from wild-type virions .

What are the key methodological challenges in determining the cryo-EM structure of HIV-1 Pol polyprotein?

Determining the cryo-EM structure of HIV-1 Pol polyprotein presents several methodological challenges that researchers must address :

  • Protein stability: The HIV-1 Pol polyprotein is prone to autocatalytic cleavage due to the presence of active protease. This necessitates introducing an inactivating mutation (D25A) in the protease domain.

  • Structural heterogeneity: Gel filtration elution peaks typically show shoulders, suggesting the presence of conformational or compositional heterogeneity that can complicate structural determination.

  • Domain flexibility: Certain regions, such as the C-terminal portion of the RTp51L subunit, exhibit high conformational flexibility, resulting in weak or absent density in reconstructions.

  • Resolution limitations: The inherent flexibility of multi-domain proteins like HIV-1 Pol can limit the achievable resolution in cryo-EM reconstructions.

To overcome these challenges, researchers have developed strategies including protein engineering to stabilize the construct, optimized purification protocols to reduce heterogeneity, and advanced computational approaches to handle flexible regions during image processing and reconstruction .

What approaches can be used to investigate the accessibility of specific cleavage sites in the folded p66 homodimer?

Investigating the accessibility of specific cleavage sites in the folded p66 homodimer requires a multifaceted approach combining structural, biochemical, and computational methods :

  • Site-directed spin labeling and DEER EPR: This approach can measure distances between specific residues surrounding cleavage sites, providing insights into their spatial accessibility .

  • Limited proteolysis assays: Exposing the p66 homodimer to HIV-1 protease under controlled conditions and analyzing the cleavage products by mass spectrometry can directly assess site accessibility.

  • Mutation studies: Introducing mutations at or near cleavage sites and assessing their impact on processing efficiency can reveal structural determinants of accessibility.

  • Cryo-EM analysis: Direct visualization of the folded polyprotein can reveal how certain cleavage sites are exposed or sequestered within the three-dimensional structure .

  • Computational modeling: Molecular dynamics simulations can predict the dynamic behavior of cleavage sites and their accessibility to protease.

Research using these approaches has revealed that the F440/Y441 cleavage site in the RTp66L is sequestered in the folded polyprotein and inaccessible for cleavage, while the corresponding site in RTp51L remains accessible, explaining the selective processing during maturation .

How does understanding HIV-1 p66 Pol processing contribute to antiretroviral drug development?

Understanding HIV-1 p66 Pol processing provides valuable insights for antiretroviral drug development through several mechanisms:

  • Novel drug targets: The unique structural features and processing events of p66 homodimer offer potential new targets for antiretroviral intervention. Particularly, the asymmetric nature of the homodimer and the selective cleavage of only one RNase H domain present specific interfaces that could be targeted .

  • Improved RT inhibitors: More than half of the drugs currently approved to treat HIV-1 infections are reverse transcriptase inhibitors . Detailed understanding of RT structure within the Pol polyprotein and conformational changes upon inhibitor binding can guide the design of more effective RT inhibitors with improved binding properties .

  • Protease inhibitor optimization: Knowledge of how HIV-1 protease interacts with the p66 homodimer, particularly the binding of the flexible linker between the RNase H and connection domains to the protease active site, can inform the development of protease inhibitors that specifically disrupt this interaction .

  • Maturation inhibitors: Compounds that interfere with the proper processing of the p66 homodimer could prevent the formation of functional RT, representing a distinct class of antiretrovirals targeting viral maturation .

The structural and functional insights gained from studying HIV-1 p66 Pol processing are therefore essential for continued innovation in antiretroviral therapy, particularly as drug resistance continues to pose challenges to existing treatment regimens.

How can researchers address the conformational heterogeneity in HIV-1 Pol structural studies?

Conformational heterogeneity presents a significant challenge in HIV-1 Pol structural studies, but several methodological approaches can address this issue :

  • Protein engineering: Strategic mutations or truncations can stabilize specific conformations. For example, the introduction of the D25A mutation in protease prevents autocatalytic cleavage, while mutations at the RT/IN junction (L560D/F1D) improve stability .

  • 3D classification in cryo-EM: Advanced computational approaches in cryo-EM data processing allow separation of different conformational states from a single dataset, enabling reconstruction of multiple states from heterogeneous samples.

  • Ensemble approaches in EPR: DEER EPR data analysis can model distance distributions as ensembles of conformations, providing insights into the range of states accessible to the protein .

  • Ligand stabilization: Binding of inhibitors or substrates can stabilize specific conformational states, reducing heterogeneity and facilitating structural determination .

  • Time-resolved studies: Techniques such as time-resolved cryo-EM or EPR can capture conformational transitions, providing a dynamic view of the protein's behavior.

By integrating these approaches, researchers can transform conformational heterogeneity from an obstacle into an opportunity to understand the dynamic nature of HIV-1 Pol, potentially revealing functionally relevant states that might be targeted by novel therapeutic approaches.

Product Science Overview

Introduction

The Human Immunodeficiency Virus type 1 (HIV-1) is a retrovirus responsible for the acquired immunodeficiency syndrome (AIDS). One of the critical enzymes in the HIV-1 lifecycle is the reverse transcriptase (RT), which is essential for converting the viral RNA genome into DNA, allowing it to integrate into the host cell’s genome. The HIV-1 reverse transcriptase is a heterodimer composed of two subunits: p66 and p51 .

Structure and Function

The p66 subunit of HIV-1 reverse transcriptase is a 66 kDa protein encoded by the pol gene. It is glycosylated with N-linked sugars and produced using baculovirus vectors in insect cells . The p66 subunit possesses both RNA-dependent and DNA-dependent DNA polymerase activities, as well as RNase H activity, which are crucial for the reverse transcription process .

The p51 subunit, on the other hand, shares the same N-terminal sequence as p66 but lacks the C-terminal 140 amino acids. This structural difference makes p51 essential for providing structural and conformational stability to the RT enzyme .

Post-Translational Modifications

HIV-1 reverse transcriptase can undergo post-translational modifications, which may play a significant role in regulating its activity. Major isoforms of the p66 and p51 subunits have been observed in virions and infected cells, suggesting that these modifications are important for the enzyme’s function inside the cell .

Recombinant Production

Recombinant HIV-1 p66 pol is produced using baculovirus vectors in insect cells. This method allows for the production of large quantities of the protein, which can be used for various research and therapeutic purposes .

Importance in Research and Therapeutics

The recombinant HIV-1 p66 pol protein is widely used in research to study the mechanisms of reverse transcription and to develop antiretroviral drugs. Understanding the structure and function of this enzyme is crucial for designing inhibitors that can effectively target and block the reverse transcription process, thereby preventing the replication of the virus .

Quick Inquiry

Personal Email Detected
Please use an institutional or corporate email address for inquiries. Personal email accounts ( such as Gmail, Yahoo, and Outlook) are not accepted. *
© Copyright 2024 Thebiotek. All Rights Reserved.